University of Helsinki-ko ikertzaileekin lankidetzan egindako argitalpenak (56)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Intelligent digital tools for screening of brain connectivity and dementia risk estimation in people affected by mild cognitive impairment: the AI-Mind clinical study protocol

    Frontiers in Neurorobotics, Vol. 17

  3. Nutrition education in medical schools (NEMS) project: Promoting clinical nutrition in medical schools – Perspectives from different actors

    Clinical Nutrition

  4. Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial

    The Lancet Respiratory Medicine, Vol. 11, Núm. 10, pp. 894-904

  5. Sex differences in the effectiveness of first-line tumour necrosis factor inhibitors in axial spondyloarthritis: Results from the EuroSpA Research Collaboration Network

    RMD Open, Vol. 9, Núm. 4

  6. WAO consensus on DEfinition of Food Allergy SEverity (DEFASE)

    World Allergy Organization Journal, Vol. 16, Núm. 3

2022

  1. Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers

    Communications biology, Vol. 5, Núm. 1, pp. 1061

  2. Erratum: Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk (European journal of human genetics : EJHG (2022) 30 3 (349-362))

    European journal of human genetics : EJHG

  3. Improving the reporting of allergic adverse events during immunotherapy for food allergy

    Journal of Allergy and Clinical Immunology

  4. Incorporating progesterone receptor expression into the PREDICT breast prognostic model

    European Journal of Cancer, Vol. 173, pp. 178-193

  5. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  6. Polygenic risk modeling for prediction of epithelial ovarian cancer risk

    European journal of human genetics : EJHG, Vol. 30, Núm. 3, pp. 349-362

2021

  1. Management of anaphylaxis due to COVID-19 vaccines in the elderly

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 10, pp. 2952-2964

  2. Outcome of patients with different clinical presentations of high-risk pulmonary embolism

    European Heart Journal: Acute Cardiovascular Care, Vol. 10, Núm. 7, pp. 787-796

  3. The FAST-FURO study: Effect of very early administration of intravenous furosemide in the prehospital setting to patients with acute heart failure attending the emergency department

    European Heart Journal: Acute Cardiovascular Care, Vol. 10, Núm. 5, pp. 487-496

  4. The safety and efficacy of dasatinib plus nivolumab in patients with previously treated chronic myeloid leukemia: results from a phase 1b dose-escalation study

    Leukemia and Lymphoma

  5. The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

    npj Breast Cancer, Vol. 7, Núm. 1

  6. Venous lactate improves the prediction of in-hospital adverse outcomes in normotensive pulmonary embolism

    European Journal of Internal Medicine, Vol. 86, pp. 25-31

2020

  1. Acute coronary syndromes and acute heart failure: a diagnostic dilemma and high-risk combination. A statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology

    European Journal of Heart Failure, Vol. 22, Núm. 8, pp. 1298-1314

  2. Corrigendum to “2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk” (Atherosclerosis (2019) 290 (140–205), (S0021915019314595), (10.1016/j.atherosclerosis.2019.08.014))

    Atherosclerosis